Table 4.
Required ICU therapies and outcomes in patients treated with dexamethasone vs. controls.
| Dexamethasone (n = 113) | No dexamethasone (n = 65) | ||||
|---|---|---|---|---|---|
| Required ICU therapies and outcomes | % | N | % | N | P-value |
| ICU mortality | 44.2 | 50 | 39.3 | 24 | 0.630 |
| Required ICU therapy | |||||
| ECMO | 21.2 | 24 | 15.4 | 10 | 0.429 |
| Hemofiltration | 20.4 | 23 | 27.7 | 18 | 0.273 |
| Catecholamines | 69.0 | 78 | 67.7 | 44 | 0.915 |
| Electrical cardioversion | 3.5 | 4 | 7.7 | 5 | 0.334 |
| Complications | |||||
| CPR | 3.6 | 4 | 3.1 | 2 | 0.853 |
| Bleeding | 1.8 | 2 | 7.8 | 5 | 0.102 |
| Pulmonary embolism (PE) | 4.4 | 5 | 20.0 | 13 | 0.001 |
| PE despite therapeutic anticoagulation | 6.0 | 5 | 34.4 | 11 | <0.0001 |
| Acute cardiac injury | 80.9 | 76 | 67.4 | 31 | 0.092 |
| Stroke | 2.7 | 3 | 7.7 | 5 | 0.143 |
| Deep vein thrombosis | 6.2 | 7 | 6.7 | 4 | 0.760 |
| Ventricular arrhythmia | 5.5 | 6 | 1.5 | 1 | 0.371 |
| Median | IQR | Median | IQR | ||
| Duration of ICU stay (days) | 10 | 6–16 | 13 | 6–28 | 0.055 |
| Duration of invasive ventilation (days) | 8 | 1–14 | 8 | 3–18 | 0.319 |
CPR, cardiopulmonary resuscitation; ECMO, extracorporeal membrane oxygenation; BMI, body mass index, IQR, interquartile range.